Cytomegaloviral mononucleosis without complications
ICD-10 B27.10 is a billable code used to indicate a diagnosis of cytomegaloviral mononucleosis without complications.
Cytomegaloviral mononucleosis is an infectious disease caused by the cytomegalovirus (CMV), a member of the herpesvirus family. It is characterized by symptoms similar to those of infectious mononucleosis, including fever, fatigue, sore throat, and lymphadenopathy. Unlike Epstein-Barr virus (EBV) mononucleosis, CMV mononucleosis can occur in immunocompetent individuals but is more commonly seen in immunocompromised patients. Diagnosis is typically made through serological testing, which detects CMV-specific IgM and IgG antibodies, or through PCR testing to identify viral DNA. The absence of complications, such as hepatitis or pneumonitis, distinguishes this code from other related codes. Treatment primarily focuses on supportive care, as antiviral therapy is generally reserved for severe cases or immunocompromised patients. The prognosis is generally good for healthy individuals, with most recovering fully without long-term effects.
Detailed clinical history, serological test results, and symptomatology.
Patients presenting with fever, fatigue, and lymphadenopathy.
Consideration of immunocompromised status and potential complications.
Thorough patient history and physical examination findings.
Young adults presenting with mononucleosis-like symptoms.
Differentiation from EBV and other viral infections.
Used to confirm CMV infection in patients presenting with mononucleosis symptoms.
Document the reason for testing and the results.
Infectious disease specialists may require additional serological tests.
Common symptoms include fever, fatigue, sore throat, and swollen lymph nodes. Some patients may also experience muscle aches and headaches.
Diagnosis is typically made through serological testing for CMV antibodies and PCR testing for viral DNA, along with clinical evaluation.
Treatment is primarily supportive, focusing on symptom relief. Antiviral medications may be used in severe cases or for immunocompromised patients.
